Literature DB >> 23757937

Proapoptotic activity of heterocyclic compounds containing succinimide moiety in the promyelocytic leukemia cell line HL-60.

Bozena Kuran1, Mariola Krawiecka, Jerzy Kossakowski, Mirosława Koronkiewicz, Zdzisław Chilmonczyk.   

Abstract

In the present paper, we describe proapoptotic activity of several heterocyclic compounds 9, 12, 18, 19 and 20 possessing succinimide (as well as succinimide related) moieties. The compounds properties were examined with the aid of flow cytometry on the promyelocytic leukemia cell line HL-60. The highest proapoptotic activity exhibited compound 12 (4-{4-[4-(2-methoxyphenyl)piperazin-1-yl]butyl}-1,7-diethyl-8,9-diphenyl-4-azatricyklo[5.2.1.0(2,6)]-dec-8-ene-3,5,10-trione). The synthesis of compounds 1-17 is also described. The structures of obtained compounds were characterized by 1H NMR, 13C NMR, ESI MS and/or elemental analyses.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23757937

Source DB:  PubMed          Journal:  Acta Pol Pharm        ISSN: 0001-6837            Impact factor:   0.330


  2 in total

1.  New Succinimides with Potent Anticancer Activity: Synthesis, Activation of Stress Signaling Pathways and Characterization of Apoptosis in Leukemia and Cervical Cancer Cells.

Authors:  Marcin Cieślak; Mariola Napiórkowska; Julia Kaźmierczak-Barańska; Karolina Królewska-Golińska; Anna Hawrył; Iwona Wybrańska; Barbara Nawrot
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

2.  Synthesis, anticholinesterase and antioxidant potentials of ketoesters derivatives of succinimides: a possible role in the management of Alzheimer's.

Authors:  Abdul Sadiq; Fawad Mahmood; Farhat Ullah; Muhammad Ayaz; Sajjad Ahmad; Faizan Ul Haq; Ghazan Khan; Muhammad Saeed Jan
Journal:  Chem Cent J       Date:  2015-05-26       Impact factor: 4.215

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.